Tbc1d32^b2b2284Clo

This ENU-induced mutation was isolated in a screen at the University of Pittsburgh. The molecular lesion is a T to A substitution at nucleotide +2 after coding nucleotide 1071 (c.1071+2T>A, NM_001033385) in intron 9. This changes splice donor site G-GT to G-GA (which is assumed to be inactive). (J:175213) Additional incidental mutations were detected in sequencing for the causative mutation, Tbc1d32b2b2284Clo, and may be present in stocks carrying this mutation.